July, 2020

Dr. Marcel Garcia, co-founder and Scientific Director, is appointed President and Scientific Director of NanoMedSyn by the General Assembly. This appointment follows the retirement of the President Henry-Vincent Charbonné for health reasons. Henry has presided remarkably over the company for 5 years and brought all his previous expertise acquired in large pharmaceutical companies. In particular, he achieved the company’s international development through a European H2020 grant, an agreement with the Shire/Takeda, an orphan drug designation from the EMA for the treatment of Pompe disease and the Life Sciences Grand Prize at the 16th ESSEC Senate competition.